Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 17 | $9.25 | $10.72 | $10.24 |
| Q2 2026 | 17 | $2.29 | $10.80 | $6.57 |
| Q3 2026 | 17 | -$0.34 | $0.20 | -$0.06 |
| Q4 2026 | 7 | -$8.03 | -$7.70 | -$7.84 |
| Q1 2027 | 7 | $11.85 | $12.36 | $12.07 |
| Q2 2027 | 7 | $7.91 | $8.25 | $8.05 |
| Q3 2027 | 10 | $1.42 | $1.48 | $1.44 |
| Q4 2027 | 7 | -$6.40 | -$6.13 | -$6.24 |
| Q1 2028 | 11 | $13.49 | $14.07 | $13.74 |
| Q2 2028 | 8 | $9.50 | $9.91 | $9.67 |
| Q3 2028 | 15 | $3.91 | $4.08 | $3.98 |
| Q4 2028 | 10 | -$3.29 | -$3.15 | -$3.21 |
Humana Inc. last posted its earnings results on Wednesday, April 29th, 2026. The company reported $10.31 earnings per share for the quarter, topping analysts' consensus estimates of $10.24 by $0.07. The company had revenue of 39.65 B for the quarter and had revenue of 129.66 B for the year. Humana Inc. has generated $10 earnings per share over the last year ($9.84 diluted earnings per share) and currently has a price-to-earnings ratio of 32.46. Humana Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/29/2026 | Q1 2026 | $10.24 | $9.85 | -0.39 | $39.37 B | $39.65 B |
| 02/19/2026 | Q4 2025 | N/A | -$6.61 | N/A | $32.04 B | $32.52 B |
| 11/05/2025 | Q3 2025 | $2.93 | $1.62 | -1.31 | $32.00 B | $32.65 B |
| 07/30/2025 | Q2 2025 | $5.92 | $4.52 | -1.4 | $31.87 B | $32.39 B |
| 04/30/2025 | Q1 2025 | $10.07 | $10.31 | 0.24 | $32.20 B | $32.11 B |
| 02/20/2025 | Q4 2024 | N/A | -$5.75 | N/A | $28.81 B | $29.21 B |
| 10/30/2024 | Q3 2024 | $3.40 | $3.99 | 0.59 | $28.68 B | $29.40 B |
| 07/31/2024 | Q2 2024 | $5.85 | $5.64 | -0.21 | $28.52 B | $29.54 B |
| 04/24/2024 | Q1 2024 | $6.12 | $6.13 | 0.01 | $28.52 B | $29.61 B |
| 02/15/2024 | Q4 2023 | N/A | -$4.42 | N/A | N/A | $26.46 B |
| 11/01/2023 | Q3 2023 | $7.16 | $6.74 | -0.42 | N/A | $26.42 B |
| 08/02/2023 | Q2 2023 | $8.82 | $7.70 | -1.12 | N/A | $26.75 B |
| 04/26/2023 | Q1 2023 | $9.27 | $9.91 | 0.64 | N/A | $26.74 B |
| 02/16/2023 | Q4 2022 | N/A | -$0.12 | N/A | N/A | $22.44 B |
| 11/02/2022 | Q3 2022 | $6.28 | $9.44 | 3.16 | N/A | $22.80 B |
| 07/27/2022 | Q2 2022 | $7.67 | $5.50 | -2.17 | N/A | $23.66 B |
| 04/27/2022 | Q1 2022 | $6.78 | $7.32 | 0.54 | N/A | $23.97 B |
| 02/17/2022 | Q4 2021 | N/A | -$0.11 | N/A | N/A | $21.02 B |
| 11/03/2021 | Q3 2021 | $4.61 | $11.91 | 7.3 | N/A | $21.76 B |
| 07/28/2021 | Q2 2021 | $6.86 | $4.57 | -2.29 | N/A | $20.65 B |
In the previous quarter, Humana Inc. (:HUM) reported $10.31 earnings per share (EPS) to beat the analysts' consensus estimate of $10.24 by $0.07.
The conference call for Humana Inc.'s latest earnings report can be listened to online.
The conference call transcript for Humana Inc.'s latest earnings report can be read online.
Humana Inc. (:HUM) has a recorded annual revenue of $129.66 B.
Humana Inc. (:HUM) has a recorded net income of $1.19 B.Humana Inc. has generated $9.87 earnings per share over the last four quarters.
Humana Inc. (:HUM) has a price-to-earnings ratio of 32.46 and price/earnings-to-growth ratio is -0.96.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED